References
- Lachmann SM, Hazleman BL, Watson PG. Scleritis and associated disease. Br Med J. 1978;1:88–90
- Riono WP, Hidayat AA, Rao NA. Scleritis: a clinicopathologic study of 55 cases. Ophthalmology. 1999;106:1328–1333
- Rao NA, Marak GE, Hidayat AA. Necrotizing scleritis: a clinico-pathologic study of 41 cases. Ophthalmology. 1985;92:1542–1549
- Pecorella I, La Cava M, Mannino G, et al. Diffuse granulomatous necrotizing scleritis. Acta Ophthalmol Scand. 2006;84:263–265
- Young RD, Watson PG. Microscopical studies of necrotising scleritis, I: cellular aspects. Br J Ophthalmol. 1984;68:770–780
- Usui Y, Parikh J, Goto H, et al. Immunopathology of necrotising scleritis. Br J Ophthalmol. 2008;92:417–419
- Fong LP, Sainz de la Maza M, Rice BA, et al. Immunopathology of scleritis. Ophthalmology. 1991;98:472–479
- Hedges TR 3rd, Albert DM. The progression of the ocular abnormalities of herpes zoster: histopathologic observations of nine cases. Ophthalmology. 1982;89:165–177
- Doctor P, Sultan A, Syed S, et al. Infliximab for the treatment of refractory scleritis. Br J Ophthalmol. 2010;94:579–583
- Morarji J, Joshi L, Tomkins-Netzer O, et al. Combined infliximab and rituximab in necrotising scleritis. Case Rep Ophthalmol. 2012;3:286–290
- Sobrin L, Kim EC, Christen W, et al. Infliximab therapy for the treatment of refractory ocular inflammatory disease. Arch Ophthalmol. 2007;125:895–900